We further assessed the target gene expression in the SAT of the MSL patients and found that RhoA, ROCK1, T-ERK1/2, and T-p-ERK1/2 were all downregulated in the MSL patients compared to that of the controls (Fig. 4C). The gene discussed is RHOA; the disease is multiple symmetric lipomatosis.